EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

FOXK1 promotes hormonally responsive breast carcinogenesis by suppressing apoptosis

Minghui Zhao, Tingyao Ma, Zhaohan Zhang, Yu Wang, Xilin Wang, Wenjuan Wang, Xiaohong Chen, Ran Gao, Lin Shan iD

Animal Models and Experimental Medicine · 2025

DOI: 10.1002/ame2.12382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Minghui Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Apoptosis, Forkhead Transcription Factors, Breast Neoplasms, Carcinogenesis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing High-Level Innovation and Entrepreneurship Talent Support Plan, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Globally, breast cancer constitutes the predominant malignancy in women. Abnormal regulation of epigenetic factors plays a key role in the development of tumors. Anti‐apoptosis is a characteristic of tumor cells. Therefore, exploring and identifying relevant epigenetic factors that regulate the apoptosis of tumor cells is the foundation for clarifying the pathogenesis of tumors and achieving precision antitumor therapy.

Method

This study focused on exploring the epigenetic mechanism of FOXK1 in the development of estrogen receptor‐positive (ER + ) breast cancer. We used overexpressing FLAG‐FOXK1 MCF‐7 cells to perform silver staining mass spectrometry analysis and conducted Co‐IP experiments to verify the interactions. ChIP‐seq was conducted on MCF‐7 cells to examine FOXK1's binding across the genome and its transcriptional target sites. To validate the ChIP‐seq results, qChIP, western blotting, and quantitative polymerase chain reaction (qPCR) were performed. Through TUNEL assay, cell counting assay, colony formation assay, and the mouse xenograft models, the effect of FOXK1 on breast cancer progression was detected. Finally, by analyzing online databases, the correlation between FOXK1 and the survival of breast cancer patients was examined.

Results

FOXK1 interacts with the REST/CoREST transcriptional corepression complex to transcriptionally inhibit target genes representing the apoptotic pathway. Abnormally high expression of FOXK1 prevents the apoptosis of ER + breast cancer cells in vitro and promotes ER + breast tumor progression in vivo. Furthermore, the expression of FOXK1 is negatively correlated with the survival of ER + breast cancer patients.

Conclusion

FOXK1 promotes ER + breast carcinogenesis through anti‐apoptosis and acts as a potential target for ER + breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisForkhead Transcription FactorsBreast NeoplasmsCarcinogenesisHumansFemaleAnimalsMiceMCF-7 CellsMice, NudeGene Expression Regulation, NeoplasticMice, Inbred BALB C

Stichwörter der Autor:innen

FOXK1apoptosisestrogen receptor‐positive breast cancertranscription repression

Substanzen

Forkhead Transcription FactorsFOXK1 protein, human

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
  • Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Beijing Key Laboratory of Cancer Invasion and Metastasis Research, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
  • National Human Diseases Animal Model Resource Center, The Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Beijing, China.
  • Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Beijing, China.

ORCID-Profile: Lin Shan

Förderung

  • Beijing High-Level Innovation and Entrepreneurship Talent Support Plan
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, M., Ma, T., Zhang, Z., Wang, Y., Wang, X., Wang, W., Chen, X., Gao, R., & Shan, L. (2025). FOXK1 promotes hormonally responsive breast carcinogenesis by suppressing apoptosis. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.12382

Vancouver

Zhao M, Ma T, Zhang Z, Wang Y, Wang X, Wang W, et al. FOXK1 promotes hormonally responsive breast carcinogenesis by suppressing apoptosis. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.12382

BibTeX
@article{Zhao2025,
  author = {Zhao, Minghui and Ma, Tingyao and Zhang, Zhaohan and Wang, Yu and Wang, Xilin and Wang, Wenjuan and Chen, Xiaohong and Gao, Ran and Shan, Lin},
  title = {FOXK1 promotes hormonally responsive breast carcinogenesis by suppressing apoptosis},
  journal = {Animal Models and Experimental Medicine},
  year = {2025},
  doi = {10.1002/ame2.12382}
}
Kostenlos starten →